During the past decade, Radiation Oncology Centers of Nevada Southeast conducted 128 clinical trials. In the 10-year time frame, 128 clinical trials started and 58 clinical trials were completed, i.e. on average, 45.3% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 48 clinical trials were completed. i.e. 104.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Radiation Oncology Centers of Nevada Southeast" #1 sponsor was "National Cancer Institute (NCI)" with 80 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Radiation Oncology Centers of Nevada Southeast" #1 collaborator was "National Cancer Institute (NCI)" with 84 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Radiation Oncology Centers of Nevada Southeast" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Recurrent Lung Non-Small Cell Carcinoma" (6 trials) and "Stage IV Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Radiation Oncology Centers of Nevada Southeast" in a lesser frequency.

Most popular intervention types in "Radiation Oncology Centers of Nevada Southeast" are "Drug" (135 trials), "Other" (107 trials), "Biological" (68 trials), "Procedure" (47 trials) and "Radiation" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (52 trials), "Quality-of-Life Assessment" (43 trials), "Computed Tomography" (29 trials), "Biospecimen Collection" (27 trials) and "Questionnaire Administration" (23 trials). Other intervention names were less common.

The vast majority of trials in "Radiation Oncology Centers of Nevada Southeast" are 142 trials for "All" genders, 19 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Radiation Oncology Centers of Nevada Southeast". undefined are not yet recruiting, 49 are recruiting, 80 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Radiation Oncology Centers of Nevada Southeast, 4 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Radiation Oncology Centers of Nevada Southeast, 4 "Phase 1" clinical trials were conducted, 85 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".